WEALTH Published 2025 · Fall 4 min readUpdated 2026-09-22

The protocol economy gets funded

Wall Street priced a documented protocol as an asset. Practices hold the same asset.

Written by Brookes Bruno · Founder, PrimeBodyRX

The protocol economy gets funded

Bryan Johnson's Blueprint raised $60 million to turn a personal longevity protocol into a product company — a watershed moment for the category.

What happened

A personal protocol became a funded product company, and the message the market sent with it was unambiguous: measured, documented protocols are sellable assets.

Every practice running a documented protocol with outcomes data is holding the same asset at clinic scale.

What it means in practice

The best practice: write your protocols down, measure them, and treat them like products — because the market already does.

A protocol that exists only in a clinician's head cannot be trained, audited, priced, or sold.

Sources
  • Blueprint funding announcement — citation pending review
Written by

Brookes Bruno

Founder, PrimeBodyRX

The Daily Demo

See the platform behind the reporting.

The Daily Demo walks the sourcing, prescriber review and financing these pages document. Tell us where to reach you.